Jul 14, 2021 4:05pm EDT IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units
Jun 09, 2021 7:05am EDT IMV Announces Appointment of Jeremy R. Graff, Ph.D. as Chief Scientific Officer And Addition of Clinical Advisor
Jun 08, 2021 7:05am EDT Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting
May 12, 2021 7:05am EDT IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline
